Webinar presenters, Alicia Algeciras-Schimnich, PhD, Professor of Laboratory Medicine and Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, William T. Hu, MD, PhD, FAAN, Associate Professor and Chief of Cognitive Neurology, Rutgers-RWJ Medical School, Institute for Health, Health Care Policy, and Aging Research, Rutgers Biomedical and Health Sciences; New Brunswick, NJ, and Leslie M. Shaw, PhD, Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania, Director, Clinical Toxicology Laboratory, University of Pennsylvania Perelman School of Medicine; Philadelphia, PA, discuss the increasing demand for practical, cost-effective tests to support the diagnosis of Alzheimer’s disease with the pending availability of treatment options, how CSF biomarkers help increase diagnostic accuracy in patients with and without cognitive impairment, the benefits Aβ42/Aβ40 ratio as an aid in differential diagnosis of Alzheimer’s disease versus other forms of dementia, and how to reduce obstacles to pre-analytic and analytic variability of assay results.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
This on-demand webinar originally broadcast September 15, 2021.
22 сен 2021
